Four DSCs have posted since the last DSB meeting on April 25, 2019. More information can be found here.

There was one presentation to the Board: Morphine Milligram Equivalents (LCDR Grace Chai, PharmD, Deputy Director for Drug Utilization, Division of Epidemiology II, Office of Surveillance and Epidemiology II, CDER)

Views expressed by non-CDER employees are those of the individual and not necessarily the opinion of his/her respective federal agency or institution.